IBB icon

iShares Biotechnology ETF

463 hedge funds and large institutions have $4.63B invested in iShares Biotechnology ETF in 2016 Q3 according to their latest regulatory filings, with 87 funds opening new positions, 146 increasing their positions, 137 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

7% more repeat investments, than reductions

Existing positions increased: 146 | Existing positions reduced: 137

47% less call options, than puts

Call options by funds: $650M | Put options by funds: $1.24B

Holders
463
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
25
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$650M
Puts
$1.24B
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
351
$251K
352
$249K
353
$246K
354
$245K
355
$244K
356
$238K
357
$232K
358
$232K
359
$232K
360
$232K
361
$232K
362
$231K
363
$230K
364
$229K
365
$228K
366
$226K
367
$225K
368
$224K
369
$222K
370
$215K
371
$214K
372
$213K
373
$210K
374
$210K
375
$210K